{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:08:41Z","timestamp":1768014521198,"version":"3.49.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019719","name":"Chiesi Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The purpose of this study is to evaluate the effectiveness and safety of switching from immediate-release (IR) to extended-release (ER) cysteamine in patients with nephropathic cystinosis (NC) in Spain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted an observational, retrospective, multicentre study in NC patients who received IR cysteamine for at least 12\u00a0months, switched to ER cysteamine, and received it for at least 6\u00a0months before inclusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Data were collected from nine patients (four children, five adults) 36\u00a0months before and after the switch. Despite the highly selected population, an improvement in growth, particularly in children and a significant reduction in hospitalization days was observed. A decrease in halitosis, body odour and gastrointestinal effects was reported in most of the patients who suffered before the switch, and the use of proton pump inhibitors (PPIs) decreased in some patients. The estimated glomerular filtration rate (eGFR) remained stable in patients with preserved kidney function. No significant changes in white blood cell (WBC) cystine levels were observed after the switch. There was no significant difference in the cysteamine dose received. However, some patients were receiving &amp;lt;50% of the recommended dose of cysteamine before and after the switch and showed elevated levels of WBC cystine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Switching from IR to ER cysteamine in clinical practice reduces hospital stays, improves nutritional status and growth in paediatric patients and could help to enhance treatment tolerability by reducing side effects. Furthermore, the dosing of ER cysteamine could promote therapeutic compliance and positively affect the quality of life of the NC population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae049","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T07:00:25Z","timestamp":1709794825000},"source":"Crossref","is-referenced-by-count":6,"title":["Switching from immediate- to extended-release cysteamine in patients with nephropathic cystinosis: from clinical trials to clinical practice"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1763-1098","authenticated-orcid":false,"given":"Gema","family":"Ariceta","sequence":"first","affiliation":[{"name":"Paediatric Nephrology Department, Hospital Vall d\u2019Hebr\u00f3n, Autonomous University of Barcelona, \u00a0 Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Santos","sequence":"additional","affiliation":[{"name":"Paediatric Nephrology Department, Hospital Universitario Central de Asturias, University of Oviedo , Oviedo , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"L\u00f3pez Mu\u00f1iz","sequence":"additional","affiliation":[{"name":"Nephrology Department, Complejo Hospitalario Universitario de la Coru\u00f1a , A Coru\u00f1a, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Hermida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Santiago de Compostela , Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Matoses","sequence":"additional","affiliation":[{"name":"Paediatric Nephrology Department, Hospital Universitario La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ventura","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Universitario La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma Leticia","family":"Martin-Moreno","sequence":"additional","affiliation":[{"name":"Nephrology Department, Clinica Universidad de Navarra, Navarra Institute for Health Research , Pamplona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital 12 de Octubre , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Acu\u00f1a","sequence":"additional","affiliation":[{"name":"Medical Department , Chiesi Espa\u00f1a S.A.U., Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Giner","sequence":"additional","affiliation":[{"name":"Medical Department , Chiesi Espa\u00f1a S.A.U., Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Vara","sequence":"additional","affiliation":[{"name":"Paediatric Nephrology Department, Hospital 12 de Octubre , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"2024041712203429800_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.nefro.2015.05.019","article-title":"Cistinosis en pacientes adolescentes y adultos: recomendaciones para la atenci\u00f3n integral de la cistinosis","volume":"35","author":"Ariceta","year":"2015","journal-title":"Nefrolog\u00eda"},{"key":"2024041712203429800_bib2","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1126\/science.7112129","article-title":"Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis","volume":"217","author":"Gahl","year":"1982","journal-title":"Science"},{"key":"2024041712203429800_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/0003-4819-147-4-200708210-00006","article-title":"Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy","volume":"147","author":"Gahl","year":"2007","journal-title":"Ann Intern Med"},{"key":"2024041712203429800_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.2011.277","article-title":"Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults","volume":"81","author":"Brodin-Sartorius","year":"2012","journal-title":"Kidney Int"},{"key":"2024041712203429800_bib5","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.kint.2021.06.019","article-title":"An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis","volume":"100","author":"Emma","year":"2021","journal-title":"Kidney Int"},{"key":"2024041712203429800_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jimd.12562","article-title":"Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: a multicenter sibling cohort study","volume":"46","author":"Veys","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"2024041712203429800_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00467-014-3018-x","article-title":"Cystinosis: renal glomerular and renal tubular function about compliance with cystine-depleting therapy","volume":"30","author":"Nesterova","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"2024041712203429800_bib8","first-page":"615","article-title":"Cystinosis and its treatment","volume":"269","author":"Cairns","year":"2002","journal-title":"Pharm J"},{"key":"2024041712203429800_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1067\/S0022-3476(03)00281-6","article-title":"The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine","volume":"143","author":"Dohil","year":"2003","journal-title":"J Pediatr"},{"key":"2024041712203429800_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2007.04.002","article-title":"The origin of halitosis in cystinotic patients due to cysteamine treatment","volume":"91","author":"Besouw","year":"2007","journal-title":"Mol Genet Metab"},{"key":"2024041712203429800_bib11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2215\/CJN.12321211","article-title":"A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety","volume":"7","author":"Langman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024041712203429800_bib12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2014.05.013","article-title":"Quality of life is improved and kidney function is preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate","volume":"165","author":"Langman","year":"2014","journal-title":"J Pediatr"},{"key":"2024041712203429800_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jmd2.12260","article-title":"Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-na\u00efve patients","volume":"63","author":"Vaisbich","year":"2021","journal-title":"JIMD Rep"},{"key":"2024041712203429800_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13023-021-01991-2","article-title":"A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis","volume":"16","author":"van Stein","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2024041712203429800_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-020-04722-0","article-title":"Adherence to cysteamine in nephropathic cystinosis: a unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs","volume":"36","author":"Gaillard","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"2024041712203429800_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00467-017-3856-4","article-title":"Effects of long-term cysteamine treatment in patients with cystinosis","volume":"34","author":"Ariceta","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"2024041712203429800_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ndt\/gfu329","article-title":"Cysteamine (Cystagon\u00ae) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults","volume":"30","author":"Ariceta","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2024041712203429800_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2024041712203429800_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2024041712203429800_bib20","article-title":"Annex I. Summary of Product characteristics. PROCYSBI"},{"key":"2024041712203429800_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJM198704163161602","article-title":"Cysteamine therapy for children with nephropathic cystinosis","volume":"316","author":"Gahl","year":"1987","journal-title":"N Engl J Med"},{"key":"2024041712203429800_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00467-016-3438-x","article-title":"Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study","volume":"32","author":"Ahlenstiel-Grunow","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"2024041712203429800_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ymgme.2012.06.017","article-title":"Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate","volume":"107","author":"Besouw","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"Suppl 3","key":"2024041712203429800_bib24","doi-asserted-by":"crossref","first-page":"iii114","DOI":"10.1093\/ndt\/gfx138.SP026","article-title":"Sp026 Quantification of dimethylsulfide associated with cysteamine bitartate-induced halitosis using breath analysis in cystinosis patients treated with delayed-release and immediate-release cysteamine bitartrate","volume":"32","author":"Greenbaum","year":"2017","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae049\/56887558\/sfae049.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/4\/sfae049\/57251814\/sfae049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/4\/sfae049\/57251814\/sfae049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T19:06:55Z","timestamp":1713380815000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae049\/7623602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae049","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,3,6]]},"article-number":"sfae049"}}